1Beauchamp L M, Drr G F, de Miranda P et al. Aminoacid ester prodrugs of acyclovir. Antiviral ChemChemother, 1992, 3:157
2Weller S, Blum M R, Doucette M et al. Pharma-cokinetics of the acyclovir pro-drug valaciclovir after ex-calating single and multiple-dose administration to nor-mal volunteers. Clin Pharmacol Ther, 1993, 54:585
3Soul-lawton J, Seaber E, On N et al. Absolute bioavail-ability and metabolic disposition of valaciclovir, the L-va-lyl ester of aciclovir, following oral administration to hu-mans. Antimicrob Agents Chemother, 1995, 39:2759
6Lin WR,Lin HH,Lee SS,et al.Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.J Microbiol Immunol In-fect,2001,34(2):138-142.
